Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tests aim to cut unnecessary antibiotics for lung infections in hospitals

NCT ID NCT05483309

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at whether using CT scans and a rapid sputum test (FilmArray) can improve diagnosis of hospital-acquired pneumonia (HAP). Currently, chest X-rays are often unclear, leading to misdiagnosis and overuse of antibiotics. The trial enrolled 220 adults with suspected HAP to see if these modern tests could help doctors give the right antibiotics faster. Since this is a feasibility study, its main goal was to see if a larger, more definitive trial is possible.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CT scan and FilmArray Pneumonia Panel (rapid sputum test)
What this could lead to
If successful, this could lead to a larger trial that shows how to diagnose hospital-acquired pneumonia more accurately, reduce unnecessary antibiotics, and slow antibiotic resistance.
What could go wrong
This is a small feasibility study, not a full trial. It only checks if a larger trial is possible, so it won't directly prove that these tests improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

220 people

The number who actually took part.

Started

Jun 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Stage 1: * Age ≥ 18 years * Suspected HAP\* For the purposes of this study, HAP is defined as per the BTS and FDA definitions i.e. pneumonia which develops 48 hours after an admission to hospital for an alternative diagnosis; or a new presentation to hospital with pneumonia in a patient who has been discharged from an overnight stay in hospital within the last 10 days. Stage 2: * The clinician intends to treat the patient for HAP or a hospital acquired respiratory tract infection (RTI). * A sputum sample has been obtained before 2nd dose of antibiotic. Exclusion Criteria: Stage 1: * Already received a chest X-ray to confirm suspected HAP diagnosis * Diagnosis or suspected diagnosis of ventilator acquired pneumonia * Intention to palliate rather than cure * Interventions cannot be completed before administration of second antibiotic dose\* * Cannot be randomised to low-dose, non-contrast CT scan on clinical grounds e.g. strong suspicion of PE\*\* * Pregnancy\*\*\* * Previous study participation (patients with second of third episodes of HAP will not be re-recruited) In the circumstance where a patient is diagnosed with HAP whist receiving antibiotics for a non-respiratory infection e.g. cellulitis or UTI, if the HAP diagnosis leads to a change in the antibiotic prescription to cover the HAP then that patient will be eligible for recruitment. However, if the diagnosis of HAP does not result in a change in antibiotic then the patient is not eligible. A non-contrast, low-dose thoracic CT scan is an inappropriate test for a PE and if that is high in the differential diagnosis then tick yes here. A urine pregnancy test is required as part of routine care prior to a chest X-ray or CT scan. If the test reveals the patient is pregnant, they will not be eligible for the study as they will be unable to receive a CT scan as part of this study. Pregnancy tests are not required at future time points. Stage 2: \- Following the CXR or CT the clinician decides not to treat with antibiotics for either HAP or a hospital acquired RTI.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hospital-acquired pneumonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Healthcare-Associated Pneumonia nosocomial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lancashire teaching hospitals NHS Foundation Trust

    Preston, United Kingdom

  • Liverpool University Hospitals NHS Foundation Trust

    Liverpool, L69 7BE, United Kingdom

  • Manchester University NHS Foundation Trust

    Manchester, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.